Significant survival improvement and prognostic factors of recurrent breast cancer after approval third generation aromatase inhibitors and trastuzumab

✍ Scribed by Mayumi Ishida; Shinji Ohno; Sayaka Kuba; Kazuhiro Tanaka; Chinami Koga; Sumiko Nishimura; Yoshiaki Nakamura; Tomoyuki Yoshiyama; Hidetoshi Kawaguchi

• Book ID: 113507487
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 58 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2011.08.093